Wild Bunch AG (FRA:WBAH)
32.40
+5.00 (18.25%)
Last updated: Jul 29, 2025
Intra-Cellular Therapies Revenue
Wild Bunch AG had revenue of 24.30M EUR in the half year ending June 30, 2022, a decrease of -4.08%. This brings the company's revenue in the last twelve months to 69.54M, up 41.30% year-over-year. In the year 2021, Wild Bunch AG had annual revenue of 66.62M with 25.28% growth.
Revenue (ttm)
69.54M
Revenue Growth
+41.30%
P/S Ratio
8.95
Revenue / Employee
526.83K
Employees
132
Market Cap
622.51M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2021 | 66.62M | 13.44M | 25.28% |
Dec 31, 2020 | 53.17M | -24.56M | -31.59% |
Dec 31, 2019 | 77.73M | -3.55M | -4.37% |
Dec 31, 2018 | 81.28M | -20.14M | -19.86% |
Dec 31, 2017 | 101.42M | -20.73M | -16.97% |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SAP SE | 35.89B |
Siemens Aktiengesellschaft | 77.82B |
Deutsche Telekom AG | 120.25B |
Allianz SE | 109.03B |
Rheinmetall AG | 10.48B |
Siemens Energy AG | 37.44B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 61.84B |
Deutsche Bank Aktiengesellschaft | 30.07B |